In AKI, AQP1 levels in urinary EVs slightly rose within 24 h, while AQP2 levels plummeted, suggesting that combined monitoring of AQP2 and AQP1 changes can realize diagnosis of cisplatin-induced renal damage, preceding traditional hematological markers. The gene discussed is AQP1; the disease is acute kidney injury.